Home
BCTX
BCTX News

Latest BriaCell Therapeutics Corp. (BCTX) News on May 9, 2025

GlobeNewswire

9 days ago

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

GlobeNewswire

10 days ago

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

MT Newswires

11 days ago

BriaCell Therapeutics Lower, Says Presenting Positive Phase 2 Data at AACR

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

GlobeNewswire

11 days ago

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

MT Newswires

14 days ago

BriaCell Therapeutics to Raise $13.8 Million in Public Offering; Shares Fall

MT Newswires

14 days ago

BriaCell Therapeutics Down 17% In US Premarket As Prices US$13.8 Million Public Offering

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

GlobeNewswire

14 days ago

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

MT Newswires

15 days ago

Update: BriaCell Jumps More Than 30% As Reports Complete Lung Metastasis Resolution in Patient

MT Newswires

15 days ago

BriaCell Jumps 41% in U.S. Pre-market Trading, Reports Complete Lung Metastasis Resolution in Patient

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

GlobeNewswire

15 days ago

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

BriaCell Announces Four Clinical Data Presentations at ASCO 2025

GlobeNewswire

16 days ago

BriaCell Announces Four Clinical Data Presentations at ASCO 2025

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

GlobeNewswire

17 days ago

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

MT Newswires

23 days ago

BriaCell Therapeutics Up 7% as It Reports Latest Survival Data From Phase 2 Breast Cancer Study

MT Newswires

23 days ago

Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday

MT Newswires

23 days ago

BriaCell Says Breast Cancer Therapy Shows Positive Survival Data; Shares Rise

BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer

GlobeNewswire

23 days ago

BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer

MT Newswires

a month ago

BriaCell Subsidiary Develops Antibodies to Anti-Cancer Target B7-H3

BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3

GlobeNewswire

a month ago

BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3

BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference

GlobeNewswire

a month ago

BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference

MT Newswires

2 months ago

BriaCell Therapeutics Says Data Safety Monitoring Board Recommends Continuation of Phase 3 Trial in Metastatic Breast Cancer

Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire

2 months ago

Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer

BRIACELL THERAP (BCTX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Zacks

3 months ago

BRIACELL THERAP (BCTX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

GlobeNewswire

3 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

BriaCell Therapeutics Announces Closing of Public Offering

GlobeNewswire

3 months ago

BriaCell Therapeutics Announces Closing of Public Offering

BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

3 months ago

BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?

MT Newswires

3 months ago

Top Premarket Decliners

BriaCell Therapeutics Announces Pricing of Public Offering

GlobeNewswire

3 months ago

BriaCell Therapeutics Announces Pricing of Public Offering

BriaCell Therapeutics Announces Proposed Public Offering of Common Shares

GlobeNewswire

3 months ago

BriaCell Therapeutics Announces Proposed Public Offering of Common Shares

BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™

GlobeNewswire

3 months ago

BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™

MT Newswires

3 months ago

BriaCell Therapeutics Completes 15:1 Share Consolidation

BriaCell Announces Completion of 15:1 Share Consolidation

GlobeNewswire

3 months ago

BriaCell Announces Completion of 15:1 Share Consolidation

BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025

GlobeNewswire

4 months ago

BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025

BriaCell Announces Proposed Effective Date of Share Consolidation

GlobeNewswire

4 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation

Insider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40m

Simply Wall St.

5 months ago

Insider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40m

BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

GlobeNewswire

5 months ago

BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

GlobeNewswire

5 months ago

BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

MT Newswires

5 months ago

BriaCell Therapeutics Raises $5.55 Million in an Underwritten Offering of Share Units

BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering

GlobeNewswire

5 months ago

BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering

BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer

GlobeNewswire

5 months ago

BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer

BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

GlobeNewswire

5 months ago

BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

MT Newswires

5 months ago

BriaCell Therapeutics Plans Public Offering; Shares Plunge After Hours

BriaCell Therapeutics Announces Proposed Public Offering

GlobeNewswire

5 months ago

BriaCell Therapeutics Announces Proposed Public Offering

BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®

GlobeNewswire

5 months ago

BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire

5 months ago

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

GlobeNewswire

5 months ago

BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

BriaCell Provides Update to its Board of Directors

GlobeNewswire

5 months ago

BriaCell Provides Update to its Board of Directors

BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study

GlobeNewswire

6 months ago

BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

GlobeNewswire

6 months ago

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13

GlobeNewswire

6 months ago

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13

MT Newswires

7 months ago

BriaCell Higher as it Reports "Standard-Beating" Survival Data From Phase 2 Study

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data

GlobeNewswire

7 months ago

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data

MT Newswires

7 months ago

BriaCell to Complete Patient Enrollment for Phase 3 Breast Cancer Study by Mid-2025; Shares Rise

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

GlobeNewswire

7 months ago

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

MT Newswires

7 months ago

BriaCell Therapeutics Closes Offering of 5.13 Million Shares, Warrants

BriaCell Therapeutics Announces Closing of $5 Million Offering

GlobeNewswire

7 months ago

BriaCell Therapeutics Announces Closing of $5 Million Offering

MT Newswires

7 months ago

BriaCell Therapeutics Shares Plummet After Pricing of $5 Million Offering

MT Newswires

7 months ago

BriaCell Therapeutics Down 41% as it Announces US$5-Million Share-Unit Offering

BriaCell Therapeutics Announces $5 Million Offering

GlobeNewswire

7 months ago

BriaCell Therapeutics Announces $5 Million Offering

MT Newswires

7 months ago

BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

GlobeNewswire

7 months ago

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock

Zacks

7 months ago

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock

MT Newswires

8 months ago

BriaCell Says FDA Greenlit Expanded Access Policy for Metastatic Breast Cancer Patients

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

GlobeNewswire

8 months ago

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

MT Newswires

8 months ago

BriaCell Therapeutics Closes $8.5 Million Offering

BriaCell Therapeutics Announces Closing of $8.5 Million Offering

GlobeNewswire

8 months ago

BriaCell Therapeutics Announces Closing of $8.5 Million Offering

MT Newswires

8 months ago

BriaCell Therapeutics Announces US$8.5 Million Share Offering

MT Newswires

8 months ago

Sector Update: Health Care Stocks Softer in Afternoon Trading

MT Newswires

8 months ago

BriaCell Therapeutics Prices $8.5 Million Offering

BriaCell Therapeutics Announces $8.5 Million Offering

GlobeNewswire

8 months ago

BriaCell Therapeutics Announces $8.5 Million Offering

Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday

Benzinga

8 months ago

Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday

MT Newswires

8 months ago

Update: BriaCell Shares Surge After Reporting Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study

MT Newswires

8 months ago

Sector Update: Health Care Stocks Narrowly Mixed Premarket Wednesday

MT Newswires

8 months ago

BriaCell Reports Longer Overall Survival Rate in Phase 2 Breast Cancer Study

MT Newswires

8 months ago

BriaCell Reports Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study - Shares Soar Premarket

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer

GlobeNewswire

8 months ago

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer

MT Newswires

8 months ago

BriaCell Receives Positive Feedback From FDA Meeting Over Potential Prostate Cancer Drug

BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate Cancer

GlobeNewswire

8 months ago

BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate Cancer

BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire

8 months ago

BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast Cancer

GlobeNewswire

10 months ago

BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast Cancer

BriaCell Presents Clinical Efficacy Data at ASCO 2024

GlobeNewswire

a year ago

BriaCell Presents Clinical Efficacy Data at ASCO 2024

MT Newswires

a year ago

BriaCell Begins Patient Enrollment in First-in-Human Study of Bria-OTS in Advanced Metastatic Breast Cancer

BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer

GlobeNewswire

a year ago

BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer

MT Newswires

a year ago

BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study

MT Newswires

a year ago

BriaCell Therapeutics, BeiGene Partner to Test Combination of Companies' Cancer Treatments

BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024

GlobeNewswire

a year ago

BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024

This BriaCell Therapeutics Insider Increased Their Holding By 55% Last Year

Simply Wall St.

a year ago

This BriaCell Therapeutics Insider Increased Their Holding By 55% Last Year

MT Newswires

a year ago

Briacell Therapeutics Insider Bought Shares Worth $2,000,001, According to a Recent SEC Filing

BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

GlobeNewswire

a year ago

BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

MT Newswires

a year ago

BriaCell Therapeutics Prices $5 Million Offering; Shares Tumble

BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering

GlobeNewswire

a year ago

BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering

MT Newswires

a year ago

BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting

BriaCell Announces Oral and Poster Presentations at ASCO 2024

GlobeNewswire

a year ago

BriaCell Announces Oral and Poster Presentations at ASCO 2024

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer

GlobeNewswire

a year ago

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer

BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR

GlobeNewswire

a year ago

BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR

BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies

GlobeNewswire

a year ago

BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies

BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference

GlobeNewswire

a year ago

BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference

BriaCell Provides Update on Alleged Illegal Trading of Public Securities

GlobeNewswire

a year ago

BriaCell Provides Update on Alleged Illegal Trading of Public Securities

Get Rich Quick With These 3 Penny Stocks to Buy Now

InvestorPlace

a year ago

Get Rich Quick With These 3 Penny Stocks to Buy Now

BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case

GlobeNewswire

a year ago

BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case

Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing

GlobeNewswire

a year ago

Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing

Share on Social Networks: